| Literature DB >> 29868147 |
Qi Zhang1, Feng Hao2, Jianbao Li1,3, Yangying Zhou1, Yaxuan Wei1, Hong Lin1.
Abstract
Perovskite solar cells have recently drawn significant attention for photovoltaic applications with a certified power conversion efficiency of more than 22%. Unfortunately, the toxicity of the dissolvable lead content in these materials presents a critical concern for future commercial development. This review outlines some criteria for the possible replacement of lead by less toxic elements, and highlights current research progress in the application of low-lead halide perovskites as optically active materials in solar cells. These criteria are discussed with the aim of developing a better understanding of the physio-chemical properties of perovskites and of realizing similar photovoltaic performance in perovskite materials either with or without lead. Some open questions and future development prospects are outlined for further advancing perovskite solar cells toward both low toxicity and high efficiency.Entities:
Keywords: 209 Solar cell / Photovoltaics; 40 Optical; Low-lead; magnetic and electronic device materials; metal-halide perovskite; substitution; toxicity
Year: 2018 PMID: 29868147 PMCID: PMC5974705 DOI: 10.1080/14686996.2018.1460176
Source DB: PubMed Journal: Sci Technol Adv Mater ISSN: 1468-6996 Impact factor: 8.090
Figure 1.Environmental sources of childhood lead exposure [20].
Figure 2.Elements forming halide double perovskites (elpasolites) with composition A2BB3+X6 [55].
Summary of device performance of low-lead perovskite solar cells.
| Perovskite | Device Architecture | Short-circuit current (mA·cm−2) | Open-circuit voltage (V) | Fill Factor | Power Conversion Efficiency (%) | Year | Reference |
|---|---|---|---|---|---|---|---|
| CsSnI2.95F0.05+5%SnF2 | FTO/TiO2/N719 Dye/Perovskite/ZnO | 19.2 | 0.72 | 0.73 | 10.2 | 2012 | 60 |
| CsSnI3 + 20 mol% SnF2 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/m-MTDATA /Au | 22.7 | 0.24 | 0.37 | 2.02 | 2014 | 72 |
| CsSnI2.9Br0.1 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite /Spiro-OMeTAD+Li-TFSI+tBP/Au | 24.2 | 0.22 | 0.33 | 1.76 | 2015 | 74 |
| CsSnI3/ICBA | ITO/CuI/Perovskite/Fullerene/BCP/Al | 12.3 ± 0.5 | 0.43 ± 0.06 | 0.39 ± 0.05 | 2.76 | 2015 | 62 |
| CsSnI3/PCBM | 8.9 ± 0.3 | 0.36 ± 0.03 | 0.54 ± 0.04 | 2.07 | |||
| CsSnI3/C60 | 11.6 ± 1.0 | 0.28 ± 0.03 | 0.43 ± 0.03 | 1.72 | |||
| CsSnI3 | ITO/NiOx/Perovskite/PC61BM/Al | 10.2 | 0.52 | 0.63 | 3.31 | 2016 | 77 |
| CsSnI3 + 10 mol% SnCl2 | ITO/Perovskite/PC61BM/BCP/Al | 9.9 ± 0.6 | 0.50 ± 0.01 | 0.68 ± 0.01 | 3.4 ± 0.2 | 2016 | 68 |
| Cs2SnI6 +Z907 | FTO/TiO2/Dye/Perovskite/Pt | 13.2 | 0.57 | 0.61 | 4.63 | 2014 | 78 |
| Cs2SnI6 +N719 | 14.7 | 0.63 | 0.68 | 6.32 | |||
| Cs2SnI6 +multiple | 16.9 | 0.62 | 0.66 | 6.94 | |||
| Cs2SnI6 +(with 3D PhC) | 18.6 | 0.62 | 0.68 | 7.8 | |||
| Cs2SnI6 | FTO/ZnO seed layer/ZnO nanorods/Perovskite/P3HT/Ag | 3.2 | 0.52 | 0.515 | 0.86 | 2016 | 79 |
| Cs2SnI6 | FTO/TiO2/Perovskite/P3HT/Ag | 5.4 | 0.51 | 0.35 | 0.96 | 2017 | 80 |
| MASn0.25Pb0.75I3 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/Spiro-OMeTAD/Au | 15.8 | 0.73 | 0.64 | 7.37 | 2014 | 83 |
| MASnIBr2 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/Spiro-OMeTAD/Au | 12.3 ± 0.5 | 0.82 ± 0 .03 | 0.57 ± 0.02 | 5.7 ± 0.2 | 2014 | 87 |
| MASnI3 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite /Spiro-OMeTAD+Li-TFSI+tBP/Au | 16.8 | 0.88 | 0.42 | 6.4 | 2014 | 36 |
| MASn0.5Pb0.5I3 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/P3HT/Ag/Au | 20.0 | 0.42 | 0.5 | 4.2 | 2014 | 87 |
| MAPb0.85Sn0.15I3−yCly | ITO/PEDOT:PSS/Perovskite/PC61BM/Ag | 19.1 ± 0.2 | 0.76 ± 0.01 | 0.660 ± 0.008 | 9.8 ± 0.3 | 2014 | 88 |
| MASnI3 | ITO/ZnO/Perovskite/spiro-OMeTAD/Au | 11.1 | 0.97 | 0.68 | 7.66 | 2015 | 56 |
| MASnI3 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/spiro-OMeTAD/Au | 21.4 | 0.32 | 0.46 | 3.15 | 2015 | 81 |
| MASnI3 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/PTAA/Au | 17.4 | 0.27 | 0.39 | 1.86 | 2016 | 90 |
| MASnI3 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/P3HT/Au | 4.3 | 0.50 | 0.49 | 1.12 | 2016 | 89 |
| MASn0.75Pb0.25I3 | ITO/PEDOT:PSS/Perovskite/PC61BM/C60/Ag | 22.4 ± 0.5 | 0.82 ± 0.01 | 0.78 ± 0.01 | 14.4 ± 0.6 | 2016 | 98 |
| FASnI3 + 20 mol% SnF2 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/Spiro-OMeTAD/Au | 24.5 | 0.24 | 0.36 | 2.1 | 2015 | 95 |
| FASnI3 + 10 mol% SnF2 + pyrazine | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/Spiro-OMeTAD/Au | 23.7 | 0.32 | 0.63 | 4.8 | 2016 | 96 |
| FASnI3 + 10 mol% SnF2 + diethyl ether | ITO/PEDOT:PSS/Perovskite/C60/BCP/Ag | 22.1 | 0.47 | 0.61 | 6.22 | 2016 | 97 |
| FASnI2Br | ITO/PEDOT:PSS/Perovskite/C60/Ca/Al | 6.8 | 0.47 | 0.54 | 1.72 | 2016 | 99 |
| ITO/MoOx/Perovskite/C60/Ca/Al | 2 | 0.44 | 0.55 | 0.47 | |||
| FASn0.5Pb0.5I3 | ITO/PEDOT:PSS/Perovskite/C60/BCP/Au | 21.9 | 0.70 | 0.66 | 10.2 | 2016 | 57 |
| FA0.75Cs0.25Sn0.5Pb0.5I3 | 26.7 | 0.74 | 0.71 | 14.1 | |||
| MA0.5FA0.5Pb0.75Sn0.25I3 | ITO/PEDOT:PSS/Perovskite/PC61BM/C60/Ag | 22.8 | 0.79 | 0.78 | 14.06 | 2016 | 98 |
| FASnI3 | ITO/PEDOT:PSS/Perovskite/C60/BCP/Ag | 17.8 | 0.33 | 0.68 | 3.98 | 2017 | 76 |
| CsGeI3 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/Spiro-OMeTAD/Au | 5.7 | 0.07 | 0.27 | 0.11 | 2015 | 37 |
| MAGeI3 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/Spiro-OMeTAD/Au | 4.0 | 0.15 | 0.3 | 0.2 | ||
| Cs3Bi2I9 | FTO/Compact TiO2/Mesoporous TiO2 /Perovskite/Spiro-OMeTAD/Au | 2.2 | 0.85 | 0.6 | 1.09 | 2015 | 106 |
| MA3Bi2I9 | 0.5 | 0.68 | 0.33 | 0.12 | |||
| MA3Bi2I9Clx | 0.2 | 0.04 | 0.38 | 0.003 | |||
| MA3Bi2I9 | FTO/TiO2/Anatase/Perovskite/HTL/Au | 0.8 | 0.56 | 0.48 | 0.259 | 2016 | 111 |
| FTO/TiO2/Perovskite/HTL/Au | 0.6 | 0.51 | 0.33 | 0.108 | |||
| FTO/TiO2/Brookite/Perovskite/HTL/Au | 0.6 | 0.53 | 0.3 | 0.094 | |||
| Cs3Sb2I9 | FTO/Compact TiO2/Perovskite/PTAA/Au | 0.3 | - | - | <1 | 2015 | 116 |
| MA3Sb2I9 | ITO/PEDOT:PSS/Perovskite/PC61BM/ZnO Nanoparticle /Al | 1 | 0.90 | 0.55 | 0.49 | 2016 | 118 |
| Rb3Sb2I9 | ITO/TIO2/Perovskite/Poly-TPD/Au | 2.1 | 0.55 | 0.57 | 0.66 | 2016 | 117 |
| MAPb0.85In0.15I3Cl0.15 | ITO/PEDOT:PSS/Perovskite/PC61BM/Bphen/Ag | 21.9 | 1.03 | 0.78 | 17.55 | 2016 | 119 |
| MA2CuClxBr4−x | ITO/PEDOT:PSS/Perovskite/PC61BM/Al | 0.22 | 0.26 | 0.32 | 0.017 | 2016 | 129 |
| MAPbxMn1–xI1+2xCl2–2x | ITO/PEDOT:PSS/Perovskite/PC61BM/Al | 0.02 | 1.19 | 0.88 | 0.32 | 2016 | 130 |
Notes: ITO: Tin-doped indium oxide; PEDOT:PSS: Poly(3,4-ethylenedioxy-thiophene)-poly(styrene sulfonate); PC61BM: Phenyl-C61-butyric acid methyl ester; Bphen: Bathophenanthroline; m-MTDATA: 4, 4′, 4″-tris (N, N-phenyl-3-methylamino) triphenylamine; BCP: Bathocuproine; FTO: Fluorine-doped tin oxide; N719:(cisdiisothiocyanato-bis(2,29-bipyridyl-4,49-dicaboxylato) ruthenium(II)bis-(tetra -butylammonium); P3HT: Poly(3-hexylthiophene-2,5-diyl); Poly-TPD: Poly[N,N’-bis(4-butylphenyl)-N,N’-bisphenylbenzidine]; PTAA: Poly[bis(4-phenyl)(2,4,6-trimethylphenyl)amine]; Spiro-OMeTAD: 2,2’,7,7’-Tetrakis[N,N-di(4-Methoxyphenyl)aMino]-9,9’-spirobifluorene; tBP:Tri-butyl-phosphate; PhC: Photonic crystals.
Figure 3.Crystal structure of SnI2·3DMSO, an intermediate compound in the MASnI3 film fabrication process. (a) The dimeric structure of the SnI(DMSO)3 + ions linked through the lone I− ions. (b) The unit cell of SnI2·3DMSO in parallel view. (c) A schematic of the film formation of the MASnI3 perovskite film starting from SnI2 through the SnI2·3DMSO intermediate [80].
Figure 4.Coordination environment of (a) (HA)SnI4 and (b)(BZA)2SnI4; the Pb analogues of HA2+ and BZA+ have the exact same environments. (c) Top-down view of (HA)SnI4, ‘eclipsed’ conformation; (d) ‘staggered’ conformation of (BZA)2SnI4 [58].